ulcerative colitis, inflammatory bowel disease, IBD, UC Researchers performed a systematic review of clinical trials to assess the need for a consensus on the definition of mild to moderate, active ...

Ischemic colitis reduces blood flow to the colon or large intestine. Mesenteric ischemia is a reduction in blood flow to the small intestine due to the narrowing of the arteries. Both conditions are ...

The initial manifestations of ulcerative colitis, although unpleasant and discomforting, are not necessarily alarming. Stomach cramps, diarrhoea and even rectal bleeding can arise from various ...

Fulminant colitis is a somewhat rare but serious form of ulcerative colitis (UC). UC causes inflammation and sores in the lining of the colon. It doesn’t happen to most people who have UC. Less than ...

Immune-mediated diarrhea and colitis (IMDC) is among the most common immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors (ICIs). Many factors will affect ...

For the 907,000 Americans with ulcerative colitis, living with symptoms like urgent bowel movements, abdominal cramps, and loose or bloody stools can be overwhelming, but treatments can help keep ...

Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...

(HealthDay)—A C-reactive protein (CRP) cutoff is a sensitive and practical alternative to erythrocyte sedimentation rate (ESR) as a criterion to help determine ulcerative colitis (UC) activity, ...

Fulminant colitis is a rare but severe form of colitis that can be life threatening. It affects the entire lining of the colon, causing severe inflammation and potentially serious complications. In ...

Some ulcerative colitis patients may not need to be monitored as often with invasive endoscopies, according to new guidelines from the American Gastroenterological Association (AGA). Published this ...

Biologic therapies are widely used in patients with ulcerative colitis. Head-to-head trials of these therapies in patients with inflammatory bowel disease are lacking. A total of 769 patients ...